Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alignment Healthcare (ALHC) Cash from Financing Activities (2020 - 2025)

Historic Cash from Financing Activities for Alignment Healthcare (ALHC) over the last 6 years, with Q3 2025 value amounting to $948000.0.

  • Alignment Healthcare's Cash from Financing Activities changed N/A to $948000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $109.6 million, marking a year-over-year increase of 12281.39%. This contributed to the annual value of $156.0 million for FY2024, which is 14849809.52% up from last year.
  • Alignment Healthcare's Cash from Financing Activities amounted to $948000.0 in Q3 2025.
  • In the past 5 years, Alignment Healthcare's Cash from Financing Activities registered a high of $363.7 million during Q1 2021, and its lowest value of -$3.5 million during Q2 2021.
  • For the 5-year period, Alignment Healthcare's Cash from Financing Activities averaged around $38.3 million, with its median value being $113000.0 (2023).
  • Examining YoY changes over the last 5 years, Alignment Healthcare's Cash from Financing Activities showed a top increase of 23740000.0% in 2024 and a maximum decrease of 121666.67% in 2024.
  • Quarter analysis of 5 years shows Alignment Healthcare's Cash from Financing Activities stood at -$3.5 million in 2021, then surged by 85.07% to -$527000.0 in 2022, then skyrocketed by 108.54% to $45000.0 in 2023, then skyrocketed by 237400.0% to $106.9 million in 2024, then plummeted by 99.11% to $948000.0 in 2025.
  • Its Cash from Financing Activities stands at $948000.0 for Q3 2025, versus $1.6 million for Q2 2025 and $181000.0 for Q1 2025.